NIH 'very concerned' about serious side effect in AstraZeneca coronavirus vaccine trial
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: AstraZeneca | Coronavirus | COVID-19 | Food and Drug Administration (FDA) | Health | National Institutes of Health (NIH) | UK Health | Vaccines